HYFTOR

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 73683-101
  • Package NDC 73683-101-10
  • Application number NDA213478
  • SPL ID 3cf7f2ef-f144-0632-e063-6394a90a9b9c
  • SPL set ID edb3ea90-5adc-48ec-99f5-ab963e302f18
  • UNII W36ZG6FT64
  • RxCUI 2596864
  • RxCUI 2596869

What the source publishes

Labeler
Nobelpharma America, LLC
Active ingredients
sirolimus
Form
GEL
Routes
TOPICAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:73683-101_3cf7f2ef-f144-0632-e063-6394a90a9b9c
{
  "name": "HYFTOR",
  "splId": "3cf7f2ef-f144-0632-e063-6394a90a9b9c",
  "labels": [
    {
      "setId": "edb3ea90-5adc-48ec-99f5-ab963e302f18",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=edb3ea90-5adc-48ec-99f5-ab963e302f18",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=edb3ea90-5adc-48ec-99f5-ab963e302f18"
    }
  ],
  "routes": [
    "TOPICAL"
  ],
  "labeler": "Nobelpharma America, LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 TUBE in 1 CARTON (73683-101-10)  / 10 g in 1 TUBE",
      "package_ndc": "73683-101-10",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220323"
    }
  ],
  "productId": "73683-101_3cf7f2ef-f144-0632-e063-6394a90a9b9c",
  "useDomain": "unknown",
  "dosageForm": "GEL",
  "productNdc": "73683-101",
  "deaSchedule": null,
  "genericName": "sirolimus",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "SIROLIMUS",
      "strength": "2 mg/g"
    }
  ],
  "applicationNumber": "NDA213478",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20220323",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175550",
      "N0000175625",
      "N0000175624",
      "N0000175605",
      "N0000175076"
    ],
    "unii": [
      "W36ZG6FT64"
    ],
    "rxcui": [
      "2596864",
      "2596869"
    ],
    "spl_set_id": [
      "edb3ea90-5adc-48ec-99f5-ab963e302f18"
    ],
    "pharm_class_pe": [
      "Decreased Immunologic Activity [PE]"
    ],
    "pharm_class_epc": [
      "mTOR Inhibitor Immunosuppressant [EPC]",
      "Kinase Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "mTOR Inhibitors [MoA]",
      "Protein Kinase Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Nobelpharma America, LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20261231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:73683-101_3cf7f2ef-f144-0632-e063-6394a90a9b9c"